NCT04709692View on ClinicalTrials.gov

Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions
Malaria, FalciparumMalaria, Vivax
Interventions
DRUG

(+)-SJ000557733 (SJ733)

Anti-Malarial

Trial Locations (1)

Unknown

Asociación Civil Selva Amazónica (ACSA), Iquitos

Sponsors
All Listed Sponsors
collaborator

Global Health Innovative Technology Fund

OTHER

collaborator

Eisai Inc.

INDUSTRY

collaborator

Asociacion Civil Selva Amazonica

OTHER

lead

R. Kiplin Guy

OTHER